LEASE AGREEMENT BY AND BETWEEN: Eastpark at 8A - and - Pharrnacopeia, Inc.Lease Agreement • March 16th, 2009 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
AGREEMENT, made August 20, 2003, between Eastpark at 8A, 1000 Eastpark Blvd., Cranbury, New Jersey 08512, “Landlord”; and Pharmacopeia, Inc., 3000 Eastpark Boulevard, Cranbury, NJ 08512, “Tenant”.
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 16th, 2009 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
This COLLABORATION AND LICENSE AGREEMENT (the “Agreement”), dated as of the latest date of signature appearing below (the “Execution Date”) and to be effective as of the Effective Date (as defined below), is made by and among: Pharmacopeia, Inc., a Delaware corporation having its principal place of business at 3000 Eastpark Boulevard, Cranbury, New Jersey 08512, (hereinafter referred to as “Pharmacopeia”); and Schering-Plough Ltd., a Swiss corporation having its principal place of business at Toepferstrasse 5, CH 6004 Lucerne, Switzerland, (hereinafter referred to as “SPL”). Pharmacopeia and SPL are sometimes referred to herein individually as a Party and collectively as the Parties. References to “SPL” and “Pharmacopeia” shall include their respective Affiliates (as hereinafter defined).
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 16th, 2009 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
This COLLABORATION AND LICENSE AGREEMENT (the “Agreement”), dated as of the latest date of signature appearing below (the “Execution Date”) and to be effective as of the Effective Date (as defined below), is made by and among: Pharmacopeia, Inc., a Delaware corporation having its principal place of business at 3000 Eastpark Boulevard, Cranbury, New Jersey 08512, (hereinafter referred to as “Pharmacopeia”); and Schering Corporation, a New Jersey corporation having its principal place of business at 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, U.S.A., (hereinafter referred to as “Schering”). Pharmacopeia and Schering are sometimes referred to herein individually as a Party and collectively as the Parties. References to “Schering” and “Pharmacopeia” shall include their respective Affiliates (as hereinafter defined).
LICENSE AGREEMENTLicense Agreement • March 16th, 2009 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (this “Agreement”) dated the 17th day of December, 2008 (the “Execution Date”) is entered into by and between Ligand Pharmaceuticals Incorporated, a corporation organized and existing under the laws of the State of Delaware and having its principal office at 10275 Science Center Drive, San Diego, California 92121 (“Ligand”), and SmithKline Beecham Corporation, doing business as GlaxoSmithKline, a Pennsylvania corporation with its principal office at One Franklin Plaza, Philadelphia, Pennsylvania 19101 USA (“GSK”) (each, a “Party” and collectively, the “Parties”).
